Estonian Multiomics Company OÜ

Active Registry code 16919490 OÜ Tartu linn Registered 12 Feb 2024
Compare

Estonian Multiomics Company OÜ is a OÜ based in Tartu linn, registry code 16919490, status: active. Main activity: Research and experimental development on biotechnology. There is no EMTA tax data for this company on the site.

Turnover
—
State taxes
479 €
Labour taxes
46 €
Employees
—

Q1 2026 · data from the Tax and Customs Board (EMTA)

Taxes and turnover

Q3 2024 – Q1 2026
State taxes, € Q1 2026: 479 € · −89.6% vs Q1 2025
02 0004 0006 0008 000Q3 2024 Company: 4 524 €Q3·24Q4 2024 Company: 6 785 €Q4·24Q1 2025 Company: 4 608 €Q1·25Q1 2026 Company: 479 €Q1·2602 0004 0006 0008 000Q3 2024 Company: 4 524 €Q4 2024 Company: 6 785 €Q4·24Q1 2025 Company: 4 608 €Q1 2026 Company: 479 €Q1·26
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q1 2026 — 479 46 —
Q1 2025 — 4 608 4 780 —
Q4 2024 — 6 785 7 043 —
Q3 2024 — 4 524 4 696 —

Financials by year

2024 – 2025
Net profit, € 2025: -27 732 € · +69.5% vs 2024 · industry median 0 € · above 6% of the industry
-100 000-80 000-60 000-40 000-20 00002024 Company: -90 959 € Industry median: 0 €20242025 Company: -27 732 € Industry median: 0 €2025-100 000-80 000-60 000-40 000-20 00002024 Company: -90 959 € Industry median: 0 €2025 Company: -27 732 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 5 261 € · −80.7% vs 2024
010 00020 00030 0002024 Company: 27 286 €20242025 Company: 5 261 €2025010 00020 00030 0002024 Company: 27 286 €2025 Company: 5 261 €2025
Equity, € 2025: 1 892 € · −79.1% vs 2024
02 0004 0006 0008 00010 0002024 Company: 9 041 €20242025 Company: 1 892 €202502 0004 0006 0008 00010 0002024 Company: 9 041 €2025 Company: 1 892 €2025
Employees 2025: 1 · +0.0% vs 2024 · industry median 1 · above 5% of the industry
0.00.20.40.60.81.02024 Company: 1 Industry median: 120242025 Company: 1 Industry median: 120250.00.20.40.60.81.02024 Company: 1 Industry median: 12025 Company: 1 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 — -27 732 14 044 5 261 1 892 1
2024 — -90 959 43 154 27 286 9 041 1

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Return on equity (ROE)
-1 465.8 %
Net profit / equity
Return on assets (ROA)
-527.1 %
Net profit / assets
Equity ratio
36.0 %
Equity / assets
Debt ratio
64.0 %
Liabilities / assets
Current ratio
1.56
Current assets / current liabilities
Labour cost per employee per month
1 170 €
Labour costs / employees / 12 months (incl. employer taxes)

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 24 Jun 2026 Company’s own · audited e-Äriregister
2024 12 Feb 2024 – 31 Dec 2024 30 Jun 2025 Company’s own · audited e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

  • Kristjan Vassil
    Member of a senior management body (management or supervisory board) · since 5 Sep 2024
  • Andrew Markham Thompson
    Member of a senior management body (management or supervisory board) · USA · since 13 Feb 2024

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 72111Research and experimental development on biotechnology Main
Rulings
Number, date Title Deadline State Document
Ä 50248012 / 4
28 Oct 2025
Amendment entry In force
28 Oct 2025
PDF
Ä 50248012 / M2
17 Oct 2025
Ruling to eliminate deficiencies 6 Nov 2025 Deficiencies eliminated
22 Oct 2025
PDF
Ä 50248012 / 3
25 Apr 2025
Amendment entry In force
25 Apr 2025
PDF
Ä 50248012 / M1
23 Apr 2025
Ruling to eliminate deficiencies 9 May 2025 Deficiencies eliminated
24 Apr 2025
PDF
Ä 50248012 / 2
5 Aug 2024
Amendment entry In force
5 Aug 2024
PDF
Ä 50248012
12 Feb 2024
First entry In force
12 Feb 2024
PDF

Sources: e-Äriregister and EMTA. Data updated 2 Nov 2026. Open at the source ↗ · Report an error in the data